When Lichen Planus Spreads Past the Creams
SaveLichen planus's itchy, purple, flat-topped bumps mostly respond to a topical steroid and patience — many cases clear within a year or two on their own. But mouth, nail, genital, and scalp involvement behave differently, carry different risks if left untreated, and are more likely to need a systemic medication sooner. Here is how dermatologists sort out which situation applies.
Last updated: July 2026
What Lichen Planus Looks Like, and Why It Sometimes Needs More
Lichen planus is an inflammatory condition thought to involve the immune system mistakenly attacking cells in the skin and mucous membranes, producing the classic pattern of flat-topped, itchy, purplish-red bumps — often described by the "4 Ps" — polygonal, purple, pruritic, and papular. Most cases respond to topical treatment. It spreads past the creams when involvement is widespread, painful, in a location that resists topical treatment, or dragging on for months without improvement.
The exact trigger isn't always identifiable, though certain medications, hepatitis C infection, and dental materials have all been linked to lichenoid reactions that look similar to or overlap with classic lichen planus. Because the condition can show up in several different places — skin, mouth, nails, scalp, and genital skin — each with its own texture and treatment nuance, the plan for widespread or resistant lichen planus often differs quite a bit depending on where it's concentrated.
The First-Line Steroids for Lichen Planus
The first-line steroids for lichen planus are topical, applied directly to the affected skin, and for many people that's enough — most cutaneous lichen planus resolves within one to two years even without aggressive treatment, with topical steroids mainly speeding up symptom relief rather than being strictly necessary for it to eventually clear. Intralesional steroid injections are the next step up for individual thick or stubborn plaques that don't respond to cream alone.
The transition point toward something bigger than topical treatment usually comes down to extent and location: a few plaques on the wrists or ankles are very different from widespread involvement across the trunk, painful mouth or genital lesions that interfere with eating or daily comfort, or scalp involvement threatening permanent hair loss, which raises the urgency to treat more aggressively before scarring sets in.
When It's in the Mouth
Oral lichen planus treatment often starts differently than skin-only disease, because the mouth's constant exposure to food, talking, and brushing makes topical treatment harder to keep in place and the discomfort more disruptive day to day. High-potency topical steroid gels or rinses, held in contact with the lesions rather than swallowed, are typically tried first for painful or erosive oral lesions.
Oral involvement that's erosive — with open sores rather than just the lacy white lines classic to milder oral lichen planus — tends to be more persistent and more likely to need escalation than skin-only disease, and it's monitored somewhat differently over time as well, since erosive oral lichen planus has been associated with a small increased risk of oral cancer in the affected tissue, which is part of why ongoing follow-up matters even once symptoms improve.
When It's on Genital Skin
Genital lichen planus treatment follows a similar topical-first approach to oral disease, using potent topical steroids suited for the more sensitive, moisture-exposed skin in that area. Genital involvement, like oral involvement, can be erosive and significantly uncomfortable, and it's frequently under-discussed simply because it's a harder area to bring up, which can delay treatment longer than skin-only disease typically waits.
Scarring is a real risk with untreated erosive genital lichen planus, particularly in anatomy where adhesions can form and narrow normal tissue over time, which is a stronger reason to treat proactively rather than wait out a "this will probably clear on its own" assumption that might be reasonable for a couple of plaques on an arm. A dermatologist experienced with genital dermatology, sometimes working alongside a gynecologist or urologist, is often the right team for this specifically.
When It's in the Nails
Lichen planus nail changes treatment is worth pursuing promptly, because nail involvement — thinning, ridging, splitting, or in more severe cases a scarring pattern called pterygium where the nail fold fuses to the nail bed — can cause permanent nail loss if left untreated for too long, unlike a lot of skin lichen planus that can be watched for a while without consequence.
Because permanent damage is the specific risk with nail involvement, dermatologists tend to treat it more assertively and sooner than an equivalent amount of skin-only disease, sometimes with intralesional steroid injections into the nail fold itself or a course of oral treatment specifically because of that scarring risk, rather than a wait-and-see approach.
How Long Does This Actually Last?
Lichen planus duration varies widely by where it shows up: skin-only lichen planus often resolves within one to two years, sometimes leaving temporary dark marks behind after the active bumps clear, while oral lichen planus tends to be more chronic, sometimes persisting for many years with a pattern of flares and quiet periods rather than a single resolution.
That difference in expected timeline is part of why oral and genital involvement gets escalated to systemic treatment more readily than skin-only disease — waiting out a condition that's likely to resolve in a year or two is a reasonable plan for a few plaques on the skin, but a much harder ask for someone with mouth pain that's expected to persist far longer without more active treatment.
The Systemic Step: When Creams Aren't Enough
Lichen planus treatment options move toward something systemic — oral corticosteroids, a retinoid, or an immunosuppressant such as methotrexate — when disease is widespread, rapidly progressive, or concentrated in a high-risk site like the nails or scalp, and topical measures haven't kept pace. This mirrors the escalation logic used broadly in dermatology: once topical treatment plateaus for a chronic inflammatory skin condition, systemic options enter the conversation, the same way they do for eczema that's outgrown its topical ladder 1Ref 1Sidbury R, Davis DM, Alikhan A, et al. (2024).Guidelines of care for the management of atopic dermatitis in adults with phototherapy and systemic therapies.Illustrates the general dermatology escalation logic — systemic therapy entering the conversation once topical treatment plateaus for a chronic inflammatory skin condition — using eczema as the example this framework is drawn from, not a claim specific to lichen planus..
Newer systemic options are following a similar path across autoimmune skin disease generally — oral JAK inhibitors, for instance, are already approved for other stubborn autoimmune skin conditions like severe alopecia areata, where trials showed substantial hair regrowth compared with placebo 2Ref 2King B, Ohyama M, Kwon O, et al. (2022).Two Phase 3 Trials of Baricitinib for Alopecia Areata.Cited as an example that oral JAK inhibitors are already approved and effective for other autoimmune skin diseases (severe alopecia areata), illustrating a broader treatment-class trend rather than evidence specific to lichen planus., and that same drug class is increasingly where dermatology looks first when an older systemic option isn't tolerated or isn't working. Biologic therapy has followed a comparable arc in other severe inflammatory conditions, such as psoriatic arthritis, where guidelines now favor a biologic over older oral drugs as first-line therapy in appropriate cases 3Ref 3Singh JA, Guyatt G, Ogdie A, et al. (2019).2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis.Cited as an example that biologic therapy has become favored over older oral drugs as first-line systemic treatment for another severe autoimmune inflammatory condition (psoriatic arthritis), illustrating a broader treatment trend rather than evidence specific to lichen planus. — the broader trend systemic lichen planus treatment sits within, even though the specific evidence base for lichen planus itself is smaller than for these better-studied conditions.
Bringing This to a Dermatologist
A visit to discuss escalating lichen planus goes better with specifics: how long the current patches or lesions have been active, whether the mouth, nails, genital skin, or scalp are involved in addition to the skin, how much pain or itching is interfering with eating, sleep, or daily comfort, and what's already been tried.
Because lichen planus can occasionally be linked to hepatitis C infection or triggered by certain medications, a dermatologist may ask about new prescriptions started before the rash appeared and may suggest hepatitis C testing in certain cases, particularly with widespread or atypical presentations. Bringing a list of current medications to that visit can meaningfully shorten the workup.
Common questions
Related
Skin & hair
The Long, Self-Limited Course of Lichen PlanusSkin & hair
Calming the Itch and Purple Bumps of Lichen PlanusSkin & hair
Lichen Planus in the Genital Skin
Say it back
How would you explain this to someone you love?
Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.
When Lichen Planus Needs Prompt Evaluation
- —Painful mouth or genital erosions interfering with eating, drinking, or daily comfort
- —Rapid nail changes, especially thinning or splitting that suggest early scarring
- —Scalp involvement with visible hair loss
- —A sore in the mouth or on genital skin that doesn't heal within a few weeks
This article explains how dermatologists generally decide when lichen planus needs treatment beyond a topical steroid. It is not a substitute for an in-person evaluation, which is needed to confirm the diagnosis and assess which sites are involved.
References
- 1.Sidbury R, Davis DM, Alikhan A, et al. (2024). Guidelines of care for the management of atopic dermatitis in adults with phototherapy and systemic therapies. Journal of the American Academy of Dermatology. PMID 37943240Illustrates the general dermatology escalation logic — systemic therapy entering the conversation once topical treatment plateaus for a chronic inflammatory skin condition — using eczema as the example this framework is drawn from, not a claim specific to lichen planus.
- 2.King B, Ohyama M, Kwon O, et al. (2022). Two Phase 3 Trials of Baricitinib for Alopecia Areata. New England Journal of Medicine. doi:10.1056/NEJMoa2110343Cited as an example that oral JAK inhibitors are already approved and effective for other autoimmune skin diseases (severe alopecia areata), illustrating a broader treatment-class trend rather than evidence specific to lichen planus.
- 3.Singh JA, Guyatt G, Ogdie A, et al. (2019). 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis. Arthritis Care & Research / Arthritis & Rheumatology. PMID 30499246 ✓Cited as an example that biologic therapy has become favored over older oral drugs as first-line systemic treatment for another severe autoimmune inflammatory condition (psoriatic arthritis), illustrating a broader treatment trend rather than evidence specific to lichen planus.
3 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — citations link their sources. Editorial policy